Literature DB >> 25581455

MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis.

Yasushi Horimasu1, Shinichiro Ohshimo, Francesco Bonella, Sonosuke Tanaka, Nobuhisa Ishikawa, Noboru Hattori, Nobuoki Kohno, Josune Guzman, Ulrich Costabel.   

Abstract

BACKGROUND AND
OBJECTIVE: A single nucleotide polymorphism (SNP) rs35705950 in the promoter of Mucin 5B (MUC5B) has been reported to be associated with idiopathic pulmonary fibrosis (IPF) mainly in Caucasian populations. This study was conducted to confirm the association between rs35705950 and IPF in a Japanese population.
METHODS: Genomic DNA was extracted from blood samples in 384 Japanese and 137 German subjects, and rs35705950 was detected by commercially available genotyping assay.
RESULTS: The genotype distributions of rs35705950 in Japanese patients with IPF, nonspecific interstitial pneumonia (NSIP) and healthy subjects (HS) were significantly different from those in the German counterparts (P < 0.001, P < 0.001 and P = 0.010, respectively). The rs35705950 T allele frequencies in patients with IPF, NSIP and HS were 3.4%, 1.7% and 0.8%, respectively in the Japanese, while they were 33.1%, 27.4% and 4.3%, respectively in the German cohort. The T allele frequencies in patients with IPF were significantly higher than those in HS both in the Japanese (P = 0.031) and German (P < 0.001) cohorts.
CONCLUSIONS: The association between rs35705950 and IPF was also present in this Japanese cohort, but was not as strong as the German counterpart. To our knowledge, this is the first study to successfully validate the association between rs35705950 and IPF in a Japanese ethnicity.
© 2015 Asian Pacific Society of Respirology.

Entities:  

Keywords:  genetic; interstitial lung disease; lung fibrosis; single nucleotide polymorphism

Mesh:

Substances:

Year:  2015        PMID: 25581455     DOI: 10.1111/resp.12466

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  46 in total

1.  The genetic basis of idiopathic pulmonary fibrosis.

Authors:  Jonathan A Kropski; Timothy S Blackwell; James E Loyd
Journal:  Eur Respir J       Date:  2015-04-02       Impact factor: 16.671

Review 2.  Idiopathic Pulmonary Fibrosis: A Genetic Disease That Involves Mucociliary Dysfunction of the Peripheral Airways.

Authors:  Christopher M Evans; Tasha E Fingerlin; Marvin I Schwarz; David Lynch; Jonathan Kurche; Laura Warg; Ivana V Yang; David A Schwartz
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

Review 3.  Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets.

Authors:  Justin C Hewlett; Jonathan A Kropski; Timothy S Blackwell
Journal:  Matrix Biol       Date:  2018-04-03       Impact factor: 11.583

4.  Genetic Evaluation and Testing of Patients and Families with Idiopathic Pulmonary Fibrosis.

Authors:  Jonathan A Kropski; Lisa R Young; Joy D Cogan; Daphne B Mitchell; Lisa H Lancaster; John A Worrell; Cheryl Markin; Na Liu; Wendi R Mason; Tasha E Fingerlin; David A Schwartz; William E Lawson; Timothy S Blackwell; John A Phillips; James E Loyd
Journal:  Am J Respir Crit Care Med       Date:  2017-06-01       Impact factor: 21.405

Review 5.  Idiopathic Pulmonary Fibrosis Is a Genetic Disease Involving Mucus and the Peripheral Airways.

Authors:  David A Schwartz
Journal:  Ann Am Thorac Soc       Date:  2018-11

6.  IDIOPATHIC PULMONARY FIBROSIS IS A COMPLEX GENETIC DISORDER.

Authors:  David A Schwartz
Journal:  Trans Am Clin Climatol Assoc       Date:  2016

7.  Regulation of MUC5B Expression in Idiopathic Pulmonary Fibrosis.

Authors:  Britney A Helling; Anthony N Gerber; Vineela Kadiyala; Sarah K Sasse; Brent S Pedersen; Lenore Sparks; Yasushi Nakano; Tsukasa Okamoto; Christopher M Evans; Ivana V Yang; David A Schwartz
Journal:  Am J Respir Cell Mol Biol       Date:  2017-07       Impact factor: 6.914

Review 8.  Insights from human genetic studies of lung and organ fibrosis.

Authors:  Christine Kim Garcia
Journal:  J Clin Invest       Date:  2018-01-02       Impact factor: 14.808

Review 9.  Pulmonary fibrosis in the era of stratified medicine.

Authors:  Susan K Mathai; Chad A Newton; David A Schwartz; Christine Kim Garcia
Journal:  Thorax       Date:  2016-10-31       Impact factor: 9.139

10.  MUC5B and Idiopathic Pulmonary Fibrosis.

Authors:  Ivana V Yang; Tasha E Fingerlin; Christopher M Evans; Marvin I Schwarz; David A Schwartz
Journal:  Ann Am Thorac Soc       Date:  2015-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.